PE
PEJMF.US Peijia Medical Limited
- Market cap
- USD 928M
- P/E
- -
- P/B
- 2.19x
- ROE
- -11.0%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the fiscal year ending Dec 2025.
Is PEJMF.US undervalued?
Graham numberThe Graham number of Peijia Medical Limited cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Peijia Medical Limited fundamental analysis
No fundamental analysis for Peijia Medical Limited yet.
Peijia Medical Limited stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Peijia Medical Limited
Peijia Medical Limited, together with its subsidiaries, engages in the research, development, manufacturing, and sales of transcatheter valve therapeutic and neurointerventional procedural medical devices in the People's Republic of China. It operates through Transcatheter Valve Therapeutic Business, Neurointerventional Business, and Future Technology Business segments. The company's products include transcatheter aortic valve replacement (TAVR) systems, crosslinked dry-tiss…
Full company profilePeijia Medical Limited financial statements
Peijia Medical Limited annual financial statements (CNY; K = thousand, M = million, B = billion, T = trillion)
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Income Statement | |||||||
| Revenue | 18.7M | 38.7M | 137M | 251M | 441M | 615M | 713M |
| Gross Profit | 12.0M | 25.2M | 95.7M | 176M | 325M | 434M | 486M |
| Operating Income | -222M | -209M | -550M | -552M | -416M | -230M | -195M |
| EBITDA | -518M | -2.05B | -547M | -360M | -349M | -158M | -123M |
| Net Income | -532M | -2.07B | -574M | -408M | -393M | -227M | -203M |
| EPS | -0.87 | -3.27 | -0.86 | -0.61 | -0.58 | -0.34 | -0.30 |
| Balance Sheet | |||||||
| Total Assets | 879M | 2.88B | 3.16B | 3.32B | 2.67B | 2.69B | 2.66B |
| Total Liabilities | 1.44B | 68.0M | 144M | 679M | 398M | 644M | 799M |
| Shareholders' Equity | -558M | 2.81B | 3.02B | 2.64B | 2.27B | 2.03B | 1.84B |
| Cash & Short-term Investments | 505M | 2.46B | 2.30B | 1.67B | 796M | 667M | 537M |
| Cash Flow | |||||||
| Operating Cash Flow | -103M | -181M | -436M | -376M | -631M | -5.18M | -20.9M |
| Capital Expenditure | 13.5M | 27.9M | 201M | 202M | 316M | 280M | 304M |
| Free Cash Flow | -116M | -209M | -638M | -579M | -947M | -285M | -325M |
| Ratios | |||||||
| ROE | - | -73.5% | -19.0% | -15.5% | -17.3% | -11.2% | -11.0% |
| ROA | -60.5% | -71.8% | -18.2% | -12.3% | -14.7% | -8.4% | -7.7% |
| Net Profit Margin | -2,844.9% | -5,351.6% | -420.6% | -162.6% | -89.0% | -36.8% | -28.5% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
Peijia Medical Limited dividends
Peijia Medical Limited has not paid dividends in the last 7 fiscal years.
Who owns Peijia Medical Limited
- Insiders 24.82%
- Institutions 16.02%
- Public & others 59.16%
- Shares outstanding 669M
- Free float 419M
Peijia Medical Limited company profile
- Company name
- Peijia Medical Limited
- Ticker
- PEJMF.US
- Exchange
- USA Stocks
- Sector
- Healthcare
- Industry
- Health Care Equipment & Supplies
- Employees
- 1,033
- Fiscal year end
- December
- Address
- No.18 Yangjiatian Road, Suzhou, China, 215028
- Phone
- 86 512 8187 7166
- Website
- peijiamedical.com
About Peijia Medical Limited
Peijia Medical Limited, together with its subsidiaries, engages in the research, development, manufacturing, and sales of transcatheter valve therapeutic and neurointerventional procedural medical devices in the People's Republic of China. It operates through Transcatheter Valve Therapeutic Business, Neurointerventional Business, and Future Technology Business segments. The company's products include transcatheter aortic valve replacement (TAVR) systems, crosslinked dry-tissue and polymeric tri leaflet TAVR systems, transcatheter aortic valve systems, lithotripsy valvuloplasty technology and interventional robotics technology, transseptal mitral valve replacement systems, transfemoral balloon catheter, introducer sheath, pre-shaped guidewire, detachable coils, balloon guide catheter, aspiration catheter, stent retriever, delivery balloon dilatation catheter, balloon dilatation catheter, microcatheter, micro guidewire, micro guidewire, guide catheter, distal access guide catheter, intermediate catheter, and power supply. In addition, it engages in the trading and holding business. Peijia Medical Limited was incorporated in 2012 and is headquartered in Suzhou, the People's Republic of China.
Peijia Medical Limited management
9- Dr. Yi ZhangChairman & CEO · born 1968
- Mr. Lieh TsaiChief Financial Officer · born 1980
- Mr. Kongrong PanChief Operating Officer · born 1959
- Dr. Fong Tan JianChief Technology Officer · born 1976
- Ms. Ping Ye ZhangExecutive Director · born 1968
- Ms. Hong YeExecutive Director & Company Secretary · born 1972
- Ms. Xiaoxiao ZhuangVice President of Sales · born 1983
- Ms. Hongpeng WangVice President of Marketing · born 1981
- Ms. Hing Ling Chau FCIS, FCS, L.L.M.Company Secretary · born 1975